Fetal bradycardia. A practical approach

Fetal and Maternal Medicine Review

Volumn 18, Issue 3, 2007, Pages 225-255

  Acherman, Ruben J ^a,b   Evans, William N ^a,b   Luna, Carlos F ^a,b   Castillo, William J ^a,b   Rollins, Robert ^a,b   Kip, Katrinka ^a,b   Law, Ian H ^a,c   Collazos, Juan C ^a,b   Restrepo, Humberto ^a,b  

^a Childrens Heart Center Nevada   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; DEXAMETHASONE; DIGOXIN; DIURETIC AGENT; RITODRINE; SALBUTAMOL; TERBUTALINE;

ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR CONDUCTION; BRADYCARDIA; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EMBRYOLOGY; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HEART FAILURE; HEART RHYTHM; HEART VENTRICLE ARRHYTHMIA; HUMAN; INFECTION; INTRAUTERINE GROWTH RETARDATION; LONG QT SYNDROME; M MODE ECHOCARDIOGRAPHY; MAGNETOCARDIOGRAPHY; NEUROLOGIC DISEASE; OLIGOHYDRAMNIOS; PACEMAKER; REVIEW; SINUS BRADYCARDIA; SINUS NODE DYSFUNCTION; SUPRAVENTRICULAR PREMATURE BEAT; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 36048979642     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539507001982     Document Type: Review

References (119)

1. Solt I Divon MY. Fetal surveillance text. In: Blazer S, Zimmer EZ (eds) The Embryo-Scientific Discovery and Medical Ethics. Basel: Karger; 2005: 291-308.
2. Preyer W. Physiologie Spéciale de L'Embryon Recherches sur les Phénomènes de la Vie Avant la Naissance. Paris: Ancienne Librairie Germer Baillière et Cie; 1887, 19-65.
3. Windle WF. Physiology of the fetus origin and extent of function in perinatal life. Philadelphia (PA): W. B. Saunders Co; 1940, 17.
4. Moorman AFM, de Jong F, Denyn MM, Lamers WH. Development of the cardiac conduction system. Circ Res 1998; 82: 629-44.
5. Sung RJ, Ruey J, Lauer MR. Fundamental approaches to the management of cardiac arrhythmias. Boston (MA): Kluwer Academic Publishers; 2000, 1-2.
6. Mitra AG, Laurent SL, Moore JE, Blanchard GF Jr, Chescheir NC. Transvaginal versus transabdominal Doppler auscultation of fetal heart activity: a comparative study. Am J Obstet Gynecol 1996; 175: 41-44.
7. Creasy RK, Resnik R, Iams JD. Maternal-fetal medicine. 5th ed. Philadelphia (PA): WB Saunders Co; 2004, p. 169-80.
8. Boldt T, Eronen M, Anderson S. Long-term outcome in fetuses with cardiac arrhythmias. Obstet Gynecol 2003; 102: 1372-79.
9. Fouron JC. Fetal arrhythmias: the Saint-Justine hospital experience. Prenat Diagn 2004; 24: 1068-80.
10. Jaeggi E, Nii M. Fetal brady- and tachyarrhythmias: new and accepted diagnostic and treatment methods. Semin Fetal Neonatal Med 2005; 10: 504-14.
11. Pasquini L, Seale AN, Belmar C, Oseku-Afful S, Thomas MJ, Taylor MJ et al. PR interval: a comparison of electrical and mechanical methods in the fetus. Early Hum Dev 2007; 83: 231-37.
12. Strassburger JF. Prenatal diagnosis of fetal arrhythmias. Clin Perinatol 2005; 32: 891-912.
13. Kleinman CS, Hobbins JC, Jaffe CC, Lynch DC, Talner NS. Echocardiographic studies of the human fetus: prenatal diagnosis of congenital heart disease and cardiac dysrhythmias. Pediatrics 1980; 65: 1059-67.
14. Fouron J-C, Fournier A, Proulx F, Lamarche J, Bigras JL, Boutin C et al. Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart 2003; 89: 1211-16.
15. Chan FY, Woo SK, Ghosh A, Tang M, Lam C. Prenatal diagnosis of congenital fetal arrhythmias by simultaneous pulsed Doppler velocimetry of the fetal abdominal aorta and inferior vena cava. Obstet Gynecol 1990; 76: 200-205.
16. DeVore G, Horenstein J. Simultaneous Doppler recording of the pulmonary artery and vein. J Ultrasound Med 1993; 12: 669-71.
17. Glickstein J, Buyon J, Kim M, Friedman D, PRIDE investigators. The fetal Doppler mechanical PR interval: a validation study. Fetal Diagn Ther 2004; 19: 31-34.
18. Cuneo BF, Strasburger JF, Wakai RT, Ovadia M. Conduction system disease in fetuses evaluated for irregular cardiac rhythm. Fetal Diagn Ther 2006; 21: 307-13.
19. Rein AJ, O'Donnell C, Geva T, Nir A, Perles Z, Hashimoto I et al. Use of tissue velocity imaging in the diagnosis of fetal cardiac arrhythmias. Circulation 2002; 106: 1827-33.
20. Nii M, Hamilton RM, Fenwick L, Kingdom JC, Roman KS, Jaeggi ET. Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiography. Heart 2006; 92: 1831-837.
21. Ter Braak EW, Evers IM, Erkelens DW, Visser GH. Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences. Diabetes Metab Res Rev 2002; 18: 96-105.
22. Van de Velde M, Teunkens A, Hanssens M, Vandermeersch E, Verhaeghe J. Intrathecal sufentanil and fetal heart rate abnormalities: a double-blind, double placebo-controlled trial comparing two forms of combined spinal epidural analgesia with epidural analgesia in labor. Anesth Analg 2004; 98: 1153-159.
23. Mardirosoff C, Dumont L, Boulvain M, Tramer MR. Fetal bradycardia due to intrathecal opioids for labor analgesia: a systemic review. BJOG 2002; 109: 274-81.
24. Cardosi RJ, Chez RA. Magnesium sulfate, maternal hypothermia and fetal bradycardia with loss of heart rate variability. Obstet Gynecol 1998; 92: 691-93.
25. Dunn JS, Brost BC. Fetal bradycardia after IV adenosine for maternal PSVT. Am J Emerg Med 2000; 18: 234-35.
26. Magee LA, Downar E, Sermer M, Boulton BC, Allen LC, Koren G. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 1995; 172: 1307-11.
27. Klarr JM, Bhatt-Mehta V, Donn SM. Neonatal adrenergic blockade following single dose maternal labetalol administration. Am J Perinatol 1994; 11: 91-93.
28. Zhang L, Xiao Y, He J. Cocaine and apoptosis in myocardial cells. Anat Rec 1999; 257: 208-16.
29. Mehta SK, Super DM, Salvator A, Singer L, Connuck D, Fradley LG et al. Heart rate variability in cocaine-exposed newborn infants. Am Heart J 2001; 142: 828-32.
30. Perlow JH, Schlossberg DL, Strassner HT. Intrapartum cocaine use. J Reprod Med 1990; 35: 978-80.
31. Buhimschi C, Weiner CP. Endotoxemia causing fetal bradycardia during urosepsis. Obstet Gynecol 2001; 97: 818-20.
32. Presta G, Rosati E, Giannuzzi R, Del Vecchio A, Lozupone A, Criscuolo M et al. Prolonged fetal bradycardia as the presenting clinical sign in Streptococcus agalactiae chorioamnionitis. J Perinat Med 2004; 32: 535-37.
33. Rounioja S, Rasanen J, Glumoff V, Ojaniemi M, Makikallio K, Hallman M. Intra-amniotic lipopolysaccharide leads to fetal cardiac dysfunction. A mouse model for fetal inflammatory response. Cardiovasc Res 2003; 60: 156-64.
34. Peevy KJ, Chartrand SA, Wiseman HJ, Boerth RC, Olson RD. Myocardial dysfunction in group B streptococcal shock. Pediatr Res 1985; 19: 511-13.
35. Covert RF, Schreiber MD. Three different strains of heat-killed group B beta-hemolytic streptococcus cause different pulmonary and systemic response in conscious neonatal lambs. Pediatr Res 1993; 33: 373-79.
36. Sahoo S, Klein P. Maternal complex partial seizure associated with fetal distress. Arch Neurol 2005; 62: 1304-305.
37. Kramer DC, Fleischer FS, Marx GF. Fetal bradycardia resulting from maternal hypoglycemia. A report of two cases. J Reprod Med 1995; 40: 394-96.
38. Aboud E, Neales K. The effect of maternal hypothermia on the fetal heart rate. Int J Gynaecol Obstet 1999; 66: 163-64.
39. Rayyan M, Price V, Kruger M. Neonatal cholinesterase inhibitor poisoning: materno-fetal exchange of pesticide. J Paediatr Child Health 2005; 41: 152-53.
40. Belson M, Morgan BW. Methanol toxicity in a newborn. J Toxicol Clin Toxicol 2004; 42: 673-77.
41. Ong BY, Baron K, Stearns EL, Baron C, Paetkau D, Segtro R. Severe fetal bradycardia in a pregnant surgical patient despite normal oxygenation and blood pressure. Can J Anaesth 2003; 50: 922-25.
42. Rafla NM, Cook JR. The effect of maternal exercise on fetal heart rate. J Obstet Gynaecol 1999; 19: 381-84.
43. Yazicioglu HF, Hartwig D, Von Witzleben-Schurholz EV, Neppert J, Gembruch U. Fetal bradycardia following intrauterine platelet transfusion: might elevated levels of donor soluble CD40 ligand play a role. Acta Obstet Gynecol Scand 2004; 83: 868-69.
44. Ulm MR, Bettelheim D, Ulm B, Frigo P, Bernashek G. Fetal bradycardia following cordocentesis. Prenat Diagn 1997; 17: 919-23.
45. Yoon BH, Kim WJ, Eun GS, Kim SH, Syn HC, Kim SW. Tetanic uterine contraction may be a cause of persistent fetal bradycardia after fetal blood sampling by ultrasound-guided cordocentesis. Asia Oceania J Obstet Gynaecol 1992; 18: 207-209.
46. Hasegawa J, Matsuoka R, Ichizuka K, Sekizawa A, Okai T. Velamentous cord insertion: significance of prenatal detection to predict perinatal complications. Taiwan J Obstet Gynecol 2006; 45: 21-25.
47. Hadegawa J, Matsuoka R, Ichizuka K, Sekizawa A, Farina A, Okai T. Velamentous cord insertion into the lower third of the uterus is associated with intrapartum fetal heart rate abnormalities. Ultrasound Obstet Gynecol 2006; 27: 425-29.
48. Salani R, Theiler RN, Lindsay M. Uterine torsion and fetal bradycardia associated with external cephalic version. Obstet Gynecol 2006; 108: 820-22.
49. Sheiner E, Hadar A, Hallak M, Katz M, Mazor M, Shoham-Vardi I. Clinical significance of fetal heart rate tracing during the second stage of labor. Obstet Gynecol 2001; 97: 747-52.
50. Parer JT, King T, Flanders S, Fox M, Kilpatrick SJ. Fetal academia and electronic fetal heart rate patterns: is there evidence of an association? J Matern Fetal Neonatal Med 2006; 19: 289-94.
51. Williams KP, Galerneau F. Fetal heart rate parameters predictive of neonatal outcome in the presence of a prolonged deceleration. Obstet Gynecol 2002; 100: 951-54.
52. Loghis C, Salamalekis E, Panayotopoulos N, Vitoratos N, Zourlas PA. The effect of early second stage bradycardia on newborn status. Eur J Obstet Gynecol Reprod Biol 1997; 72: 149-52.
53. Ridgeway JJ, Weyrich DL, Benedetti TJ. Fetal heart rate changes associated with uterine rupture. Obstet Gynecol 2004; 103: 506-12.
54. Dubuisson J, Pennehouat G, Rudigoz RC. Spontaneous rupture of the uterine pedicle during pregnancy: Three case reports. Gynecol Obstet 2006; 34: 711-15.
55. Levy R, Furman B, Hagay ZJ. Fetal bradycardia and disseminated coagulopathy: atypical presentation of amniotic emboli. Acta Anesthesiol Scand 2004; 48: 1214-215.
56. Qu Y, Baroudi G, Yue Y, Boutjdir M. Novel molecular mechanism involving 1D (Cav1.3) L-type calcium channel in autoimmune-associated sinus bradycardia. Circulation 2005; 111: 3034-41.
57. Milanesi R, Baruscotti M, Gnecchi-Ruscone T, DiFrancesco D. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med 2006; 354: 151-57.
58. Mehta AV, Chidambaram B, Garrett A. Familial symptomatic sinus bradycardia: autosomal dominant inheritance. Pediatr Cardiol 1995; 16: 231-34.
59. Beinder E, Grancay T, Menendez T, Singer H, Hofbeck M. Fetal sinus bradycardia and the long QT syndrome. Am J Obstet Gynecol 2001; 185: 743-47.
60. Collazos JC, Acherman RJ, Law IH, Wilkes P, Restrepo H, Evans WN. Sustained fetal bradycardia with 1:1 atrioventricular conduction and long QT syndrome. Prenat Diagn 2007 (in press).
61. Schmitz L, Burghoff M. Images in cardiovascular medicine. Magnetocardiography in a fetus with long-QT syndrome. Circulation 2005; 112: e68-69.
62. Hosono T, Kawamata K, Chiba Y, Kandori A, Tsukada K. Prenatal diagnosis of long QT syndrome using magnetocardiography: a case report and review of the literature. Prenat Diagn 2002; 22: 198-200.
63. Menendez T, Achenbach S, Beinder E, Hofbeck M, Schmid O, Singer H et al. Prenatal diagnosis of QT prolongation by magnetocardiography. Pacing Clin Electrophysiol 2000; 23: 1305-307.
64. Tester DJ, McCormack J, Ackerman MJ, Prenatalmolecular diagnosis of congenital long QT syndrome by strategic genotyping. Am J Cardiol 2004; 93: 788-91.
65. Chiang C. Congenital and acquired long QT syndrome: current concepts and management. Cardiol Rev 2004; 12: 222-34.
66. Goldenberg I, Moss AJ, Maron BJ, Dick AW, Zareba W. Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias. Ann Noninvasive Electrocardiol 2005; 10: 67-83.
67. Hobbs JB, Peterson DR, Moss AJ, McNitt S, Zareba W, Goldenberg I et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT-syndrome. JAMA 2006; 296: 1249-254.
68. Scott WA, Dick II M, Two:one atrioventricular block in infants with congenital long QT syndrome. Am J Cardiol. 1987; 60: 1409-410.
69. van Hare GF, Franz MR, Roge C, Scheinman MM. Persistent functional atrioventricular block in two patients with prolonged QT intervals: elucidation of the mechanism of block. Pacing Clin Electrophysiol 1990; 13: 608-18.
70. Wu MH, Hsieh FC, Wang JK, Kau ML. A variant of long QT syndrome manifested as fetal tachycardia and associated with ventricular septal defect. Heart 1999; 82: 386-88.
71. Moss AJ, Zareba W, Hall J, Schwartz PJ, Crampton RS, Benhorin J et al. Effectiveness and limitation of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000; 101: 616-23.
72. Villain E, Denjoy I, Lupoglazoff JM, Guicheney P, Hainque B, Lucef V et al. Low incidence of Cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J 2004; 25: 1405-11.
73. Wong SF, Chau KT, Ho LC. Fetal bradycardia in the first trimester: an unusual presentation of atrial extrasystoles. Prenat Diagn 2002; 22: 976-78.
74. Webster RD, Cudmore DW, Gray J. Fetal bradycardia without fetal distress. Obstet Gynecol 1977; 50: 50s-52s.
75. Dgani R, Borenstein R, Levavi E, Feigl A, Kauli N, Lancet M. Prenatally diagnosed blocked atrial premature beats. Obstet Gynecol 1978; 51: 507-509.
76. Simpson J. Fetal arrhythmias. In: Allan L, Hornberger L, Sharland G, (eds) Textbook of Fetal Cardiology. London: Greenwich Medical Media; 2000, 423-37.
77. Schmidt K. Fetal bradyarrhythmia. In: Yagel S, Silverman N, Gembruch U, (eds) Fetal Cardiology. United Kingdom: Taylor and Francis; 2003, 345-54.
78. Saarel E, Gomez D. Fetal arrhythmia. In: Dick II Macdonald, (ed) Clinical Cardiac Electrophysiology in the Young. New York: Springer Science+Business Media; 2006, 241-56.
79. Respondek M, Wloch A, Kaczmarek P, Borowski D, Wilczynski J, Helwich E. Diagnostic and perinatal management of fetal extrasystole. Pediatr Cardiol 1997; 18: 361-66.
80. Aburawi E, Thomson J, Blackburn M. Familial idiopathic atrial fibrillation with fetal bradyarrhythmia. Acta Paediatr 2006; 95: 1700-702.
81. Buyon JP, Clancy RM. Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach. Semin Arthritis Rheum 2003; 33: 140-54.
82. Abu-Ras R, Felser K, Rottem M. Maternal antiphospholipid syndrome presenting as neonatal lupus with congenital complete heart block in the fetus. Isr Med Assoc J 2001; 3: 966-68.
83. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M. Signs of first-degree heart block occur in one third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 2004; 50: 1253-261.
84. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Weschler B, Vauthier D, Ghillani P et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003; 62: 1010-1012.
85. Glickstein JS, Buyon J, Friedman D. Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol 2000; 86: 236-39.
86. Bolnick AD, Borgida AF, Egan JF, Zelop CM. Influence of gestational age and heart rate on the fetal mechanical PR interval. J Matern Fetal Neonatal Med 2004; 15: 303-305.
87. Van Bergen AH, Cuneo BF, Davis N. Prospective echocardiographic evaluation of atrioventricular conduction in fetuses with maternal Sjogren's antibodies. Am J Obstet Gynecol 2004; 191: 1014-1018.
88. Chang YL, Hsieh PC, Chang SD, Chao AS, Lianf CC, Soong YK. Perinatal outcome of fetuswith isolated congenital second degree atrioventricular block withoutmaternal anti-SSA/Ro-SSB/La antibodies. Eur J Obstet Gynecol Reprod Biol 2005; 122: 167-71.
89. Copel JA, Buyon JP, Kleinman CS. Successful in utero therapy of fetal heart block. Am J Obstet Gynecol 1995; 173: 1384-390.
90. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block. Retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999; 42: 2335-345.
91. Breur JM, Visser GH, Kruize AA, Stoutenbeek P, Meijboom EJ. Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature. Ultrasound Obstet Gynecol 2004; 24: 467-72.
92. Michaelson M. Congenital complete atrioventricular block. Prog Pediatr Cardiol 1995; 4: 1-10.
93. Ho SY, Esscher E, Anderson RH, Michaelsson M. Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. Am J Cardiol 1986; 58: 291-94.
94. Singh GK, Shumway JB, Amon E, Marino CJ, Nouri S, Winn HN. Role of fetal echocardiography in the management of isolated fetal heart block with ventricular rate ≥55 bpm. Am J Perinatol 1998; 15: 661-68.
95. Berg C, Geipel A, Kohl T, Breuer J, Germer U, Baschat AA et al. Atrioventricular block detected in fetal life: associated anomalies and potential prognostic makers. Utrasound Obstet Gynecol 2005; 26: 4-15.
96. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Transplacental fetal treatment improves outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 2004; 110: 1542-548.
97. Eronen M, Heikkila P, Termo K. Congenital complete heart block in the fetus: hemodynamic features, antenatal treatment, and outcome in six cases. Pediatr Cardiol 2001; 22: 385-92.
98. Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen BM, Silverman NH et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 2002; 105: 843-48.
99. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis. A prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-835.
100. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national lupus registry. J Am Coll Cardiol 1998; 31: 658-66.
101. Askanase AD, Friedman DM, Copel J, Dische MR, Dubin A, Starc TJ et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus 2002; 11: 145-51.
102. Tran HB, Macardle PJ, Hiscock J, Cavill D, Bradley J, Buyon JP et al. Anti-La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus. Arthritis Rheum 2002; 46: 1572-579.
103. Brucato A, Cimaz R, Stramba-Badiale M. Neonatal Lupus. Clin Rev Allergy Immunol 2002; 23: 279-99.
104. Litsey SE, Noonan JA, O'Connor WN, Cottrill CM, Mitchell B. Maternal connective tissue disease and congenital heart block: demonstration of immunoglobulin in cardiac tissue. N Engl J Med 1985; 312: 98-100.
105. Groves AM, Allan LD, Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart 1998; 75: 190-194.
106. Stinstra J, Golbach E, Van Leeuwen P, Lange S, Menendez T, Moshage W et al. Multicenter study of fetal cardiac time intervals using magnetocardiography. Br J Obstet Gynaecol 2002; 109: 1235-243.
107. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999; 341: 1190-196.
108. Rosenthal D, Druzin M, Chin C, Dubin A. A new therapeutic approach to the fetus with congenital complete heart block: Preemptive, targeted therapy with dexamethasone. Obstet Gynecol 1998; 92: 689-91.
109. Kleinman CS, Nehgme RA. Cardiac arrhythmias in the human fetus. Pediatr Cardiol 2004; 25: 234-51.
110. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 1991; 17: 1360-366.
111. Machado MV, Tynan MJ, Curry PV, Allan LD. Fetal complete heart block. Br Heart J 1988; 60: 512-515.
112. Friedman RA, Fenrich AL, Kertesz NJ. Congenital complete atrioventricular block. Pacing Clin Electrophysiol 2001; 24: 1681-688.
113. Jaeggi ET, Hornberger LK, Smallhorn JF, Fouron JC. Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature. Ultrasound Obstet Gynecol 2005; 26: 16-21.
114. Merz, Eberhard. Anomalies and Diseases of the Fetal Heart. In: Ultrasound in Gynecology and Obstetrics. Stuttgart: Georg Thieme Verlag; 2004, 286-290.
115. Atkinson DE, Drant S. Diagnosis of heterotaxy syndrome by fetal echocardiography. Am J Cardiol 1998; 82: 1147-149, A10.
116. Phoon CK, Villegas MD, Ursell PC, Silverman NH. Left atrial isomerism detected in fetal life. Am J Cardiol 1996; 77: 1083-088.
117. Gutierrez-Roelens I, Sluysmans T, Gewillig M, Devriendt K, Vikkula M. Progressive AV- block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKZ2-5 gene. Hum Mutat 2002; 20: 75-76.
118. Bührer C, van Landeghem FK, Felderhoff-Mueser U, Stadelmann C, Obladen M. Fetal bradycardia at 28 weeks of gestation associated with cardiac glycogen phosphorylase b kinase deficiency. Acta Paediatr 2003; 92: 1352-353.
119. Özkutlu S, Önderoǧlu L, Karagöz T, Çeliker A, Şahiner ÜM. Isolated noncompaction of the left ventricular myocardium with fetal sustained bradycardia due to sick sinus syndrome. Turk J Pediatr 2006; 48: 383-86.